SCHEMBL18440482

SCHEMBL18440482

CCN(C(C)=O)C(C)(C)C1CCN(C(=O)O)CC1

nearest known ligand 0.33

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NPY2R P49146 3/20 0.33
OPRD1 P41143 3/20 0.33
CYP2D6 P10635 1/20 0.33
KCNH2 Q12809 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
CPN1 P15169 1/20 0.31
CPB2 Q96IY4 1/20 0.31
EPHX2 P34913 1/20 0.31
HSD11B1 P28845 1/20 0.31
LMNA P02545 1/20 0.31
PDK2 Q15119 2/20 0.31
CHRM2 P08172 1/20 0.30
CHRM3 P20309 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18469974 0.84 HTR1A (0.36) OPRD1LMNACHRM3TSHR
SCHEMBL18440594 0.77 CCR5 (0.40) OPRD1CPN1CPB2LMNAPDK2
SCHEMBL18469990 0.76 ARG1 (0.32) OPRD1TSHR
Hydrochloric Acid SCHEMBL18428967 0.74 GNAI3 (0.33) TSHR
SCHEMBL5765556 0.72 CYP2D6 (0.55) CYP2D6KCNH2HRH3EPHX2HSD11B1
Hydrochloric Acid SCHEMBL29034671 0.70 CYP2D6 (0.53) CYP2D6KCNH2HRH3EPHX2HSD11B1
SCHEMBL21597922 0.70 PIN1 (0.36) OPRD1CPN1CPB2LMNAPDK2
SCHEMBL4476428 0.69 CYP2D6 (0.38) NPY2RCYP2D6KCNH2HRH3EPHX2
SCHEMBL18440517 0.69 LMNA (0.37) NPY2RCYP2D6KCNH2HRH3EPHX2
SCHEMBL28697491 0.69 NPY2R (0.34) NPY2RCYP2D6KCNH2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107949558-B Muscarinic agonists 赫普泰雅治疗有限公司 2022-03-15 CN disclosed
EP-3331869-A1 MUSCARINIC AGONISTS Heptares Therapeutics Limited (GB) 2018-06-13 EP disclosed
WO-2017021730-A1 MUSCARINIC AGONISTS HEPTARES THERAPEUTICS LIMITED (GB) 2017-02-09 WO disclosed